Development and validation of a novel online calculator for estimating survival benefit of adjuvant transcatheter arterial chemoembolization in patients undergoing surgery for hepatocellular carcinoma

[1]  T. Pawlik,et al.  Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis , 2020, Therapeutic advances in gastroenterology.

[2]  K. Olthoff,et al.  Advances in resection and transplantation for hepatocellular carcinoma. , 2020, Journal of hepatology.

[3]  Jingfeng Liu,et al.  Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: a meta-analysis , 2019, Scandinavian journal of gastroenterology.

[4]  A. Villanueva.  Hepatocellular Carcinoma. , 2019, The New England journal of medicine.

[5]  C. Li,et al.  Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China , 2019, JAMA surgery.

[6]  Zhao-You Tang,et al.  Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study , 2018, Clinical Cancer Research.

[7]  W. Lau,et al.  Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion , 2016, Annals of Surgical Oncology.

[8]  M. Schwartz,et al.  Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. , 2015, Annals of surgery.

[9]  G. Gores,et al.  Hepatocellular carcinoma: clinical frontiers and perspectives , 2014, Gut.

[10]  Fan Zhou,et al.  Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. , 2009, American journal of surgery.

[11]  W. Lau,et al.  A Prospective, Randomized, Controlled Trial of Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular Carcinoma , 2009, Annals of surgery.

[12]  M. Schwartz,et al.  Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. , 2002, The Lancet. Oncology.

[13]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[14]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.